Tomorrow’s access & affordability solutions today

This is a reprint of 'The Future of Integrated Care: Redefining Specialty Medication Access and Affordability' originally published on beckershospitalreview.com on April 1, 2026.

Copay programs need to be highly scalable and flawlessly compliant in an increasingly complex healthcare space. Find out how CoverMyMeds can help.

Access and affordability challenges and their solutions are different for drug brands depending on their lifecycle stage. CoverMyMeds presented a webinar with Fierce Pharma discussing their findings, summarized here.

At HLTH USA 2025, Kevin Kettler, President of CoverMyMeds, joined fellow healthcare leaders on the panel session, “Patients Know First,” to explore how the industry can better align with the evolving expectations to ensure patients remain at the center of all decisions.

Dimensionalizing healthcare means looking beyond patient medical records to see and treat the whole person.

In this white paper, we'll discuss how pharma manufacturers can use data and insights to drive affordable medication access for patients.

Copay and discount cards abound by the hundreds, but they aren’t always easy to find and come with different applications and drawbacks. Healthcare stakeholders can help patients understand the their options while technology can play a critical hand.  

I’m excited to announce the unification of RelayHealth, McKesson Prescription Automation, CoverMyMeds, and RxCrossroads by McKesson as one business and one team under the CoverMyMeds brand.

Answers to typical questions like medication history and symptoms during a medical appointment can help lead to a diagnosis. But answers to questions left unasked could be key in finding the right treatment plan for the patient.

AMP: Access for More Patients, a new technology-driven solution from CoverMyMeds and RxCrossroads by McKesson, solves for many challenges accompanying specialty meds by leveraging network connections and creating efficiencies within provider workflows.